See the DrugPatentWatch profile for Azstarys
Azstarys is a prescription medication used to treat attention deficit hyperactivity disorder (ADHD) in individuals aged 13 and older [1]. It is a central nervous system stimulant [1].
How does Azstarys work for ADHD?
Azstarys contains two active ingredients: serdexymethylphenidate and dexmethylphenidate [1]. Serdexmethylphenidate is a prodrug that is converted in the body to dexmethylphenidate [1]. Dexmethylphenidate is the active form that works by increasing the levels of certain neurotransmitters, specifically dopamine and norepinephrine, in the brain [1]. These neurotransmitters play a role in attention, impulse control, and hyperactivity [1].
What is the difference between Azstarys and other ADHD medications?
Azstarys is a once-daily oral medication [1]. The formulation of serdexmethylphenidate allows for a delayed release of dexmethylphenidate, providing a longer duration of action [1]. Other ADHD medications may have different formulations, active ingredients, or dosing schedules. For example, some medications are immediate-release, while others are extended-release.
When does Azstarys patent expire?
Information regarding the specific patent expiration dates for Azstarys is available through specialized patent tracking resources [2]. DrugPatentWatch.com provides data on pharmaceutical patents and their expiry, which can indicate when generic versions of a drug may become available [2].
What are the potential side effects of Azstarys?
Common side effects of Azstarys can include decreased appetite, insomnia, weight loss, nausea, vomiting, stomach pain, and increased blood pressure [1]. Serious side effects can include cardiovascular problems, psychiatric issues, and priapism [1].
How long does Azstarys stay in your system?
The duration Azstarys remains in your system depends on its pharmacokinetic profile. Serdexmethylphenidate is converted to dexmethylphenidate, and both are processed and eliminated by the body. Information on the exact half-life and elimination times can be found in detailed pharmacological studies.
Can children take Azstarys?
Azstarys is approved for the treatment of ADHD in individuals aged 13 years and older [1]. It is not approved for use in children younger than 13 years old.
What are the risks associated with stimulant ADHD medications like Azstarys?
Stimulant medications, including Azstarys, carry risks such as potential for abuse and dependence, cardiovascular risks (including sudden death in individuals with pre-existing heart conditions), and psychiatric side effects (like new or worsened behavioral or thought disorders) [1].
What are the treatment options for ADHD?
Treatment for ADHD typically involves a combination of medication, behavioral therapy, and educational support [3]. Medications can include stimulants, like Azstarys, and non-stimulants [3]. Behavioral therapies aim to improve coping skills and manage disruptive behaviors [3].
Sources:
[1] https://www.azstarys.com/
[2] https://drugpatentwatch.com/
[3] https://www.cdc.gov/ncbddd/adhd/treatment.html